Boehringer's Pradaxa- First Pill to Replace Warfarin

The National Institute of Health and Clinical Excellence (NICE), UK has recommended
Boehringer Ingelheim's new anti-coagulant Pradaxa (dabigatran) for the prevention of stroke and systemic embolism in patients with atrial fibrillation (AF).

This oral medicine is an alternative to Warfarin which has been the standard blood thinner since mid 1950. Unlike Warfarin; dabigatran does not require frequent blood tests to monitor treatment. This is a significant benefit for many patients with AF.

Anticoagulation Therapy / Blood Thinners - Injectable - Oral - Indications
Anticoagulants prevent the clotting of blood in our body. They are administered orally or via injection.

Boehringer beat Xarelto, from Bayer AG (BAYN.XE) and Johnson & Johnson (JNJ), and Eliquis from Bristol-Myers Squibb Co.(BMY) and Pfizer Inc. (PFE) to become the first pill to replace warfarin.

However the final guidance on Pradaxa will be issued by NICE only in the next month.Â

Source-Medindia

Pulmonary Arterial Hypertension [PAH] - Symptoms & Signs - Causes - Diagnosis - Treatment
Pulmonary arterial hypertension can be a serious condition affecting the heart. It is defined as mean pulmonary arterial pressure >25mm Hg at rest and >30mm Hg on exertion.

New Drug Better Than Aspirin in Preventing Stroke in Patients With Atrial Fibrillation
A new experimental anti-clotting drug called Apixaban has been found to be efficient in reducing the risk of stroke in patients.

Flecainide in Atrial Fibrillation is Safe and Effective Shows Study
Atrial fibrillation is one of the leading causes of abnormal heart rhythm and an old drug calked Flecainide is safe to treat this condition.